Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Danaher Corporation(DHR)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for DHR
11/03/2026: DHR (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Danaher Corporation is a diversified science and technology company that provides critical instrumentation and consumables to the life sciences and diagnostics industries. The firm is known for its rigorous Danaher Business System, which historically drives high operational efficiency and strong margins across its segments. Its primary growth story centers on increasing global demand for bioprocessing, lab automation, and molecular diagnostics. However, the company faces risks related to pharmaceutical R&D budget cycles, integration challenges from its active M&A strategy, and premium market valuation. Danaher is well-suited for long-term growth investors who value disciplined capital allocation, while those seeking immediate high-yield income may find it less suitable.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Danaher has a long history of compounding growth through innovation and strategic acquisitions. |
| Momentum investor | Mixed fit | Momentum depends on current market sentiment and technical trends, which can fluctuate with interest rates. |
| Value investor | Mixed fit | The company often trades at a premium valuation due to its high business quality and market position. |
| Dividend investor | Mixed fit | While Danaher pays a dividend, it is primarily focused on capital appreciation rather than high yield. |
| Low-risk investor | Mixed fit | The company's defensive end-markets provide some stability, but it is still subject to broader market and sector volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock is subject to broader market and healthcare sector fluctuations. |
| Valuation risk | Medium / high | Premium market multiples often leave little room for error in earnings execution. |
| Competition risk (Scientific Instrument Peers) | Medium | Intense competition from diversified players like Thermo Fisher pressures margins and innovation requirements. |
| Business quality | Strong | The company's strong franchise quality is supported by a large installed base and high recurring revenue. |
| Dividend income | Low | Dividend yields are generally modest as capital is prioritized for growth and acquisitions. |
| Execution risk | Medium | Successfully integrating large-scale acquisitions is critical to maintaining the company's growth trajectory. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -5.4% | Avg. Invested days 49 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/03/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 160.26B USD | Price to earnings Ratio 37.74 | 1Y Target Price 259.9 |
Price to earnings Ratio 37.74 | 1Y Target Price 259.9 | ||
Volume (30-day avg) 4.4M shares | Beta 0.8 | 52 Weeks Range 160.31 - 241.35 | Updated Date 11/03/2026 |
52 Weeks Range 160.31 - 241.35 | Updated Date 11/03/2026 | ||
Dividends yield (FY) 0.65% | Basic EPS (TTM) 6.04 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Biotechnology | Bioprocessing equipment and consumables for drug and vaccine manufacturing. | The company sells essential tools that labs 'consume' to make drugs, providing recurring revenue. |
| Diagnostics | Clinical laboratory instruments and reagents for disease screening and testing. | This segment is a reliable profit driver with high recurring income from the sale of test reagents. |
| Life Sciences | Mass spectrometry and imaging systems used in research and development. | High-tech equipment sales that benefit from increased global investment in life sciences R&D. |
| Geography | Global operations with significant exposure to North America, Europe, and Asia-Pacific markets. | International diversification helps mitigate regional economic downturns. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-21 | When Before Market | Estimate 1.92 | Actual 2.11 |
Profitability
Profit Margin 16.91% | Operating Margin (TTM) 21.13% |
Management Effectiveness
Return on Assets (TTM) 4.06% | Return on Equity (TTM) 8.19% |
Valuation
Trailing PE 37.74 | Forward PE 24.88 | Enterprise Value 181.06B | Price to Sales(TTM) 6.26 |
Enterprise Value 181.06B | Price to Sales(TTM) 6.26 | ||
Enterprise Value to Revenue 7.19 | Enterprise Value to EBITDA 23.57 | Shares Outstanding 702.99M | Shares Floating 626.35M |
Shares Outstanding 702.99M | Shares Floating 626.35M | ||
Percent Insiders 10.81 | Percent Institutions 83.64 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.